Neurobiology of Aging
Volume 33, Issue 3 , Pages 622.e17-622.e28, March 2012

The role of extracerebral cholesterol homeostasis and ApoE e4 in cognitive decline

  • Tessa N. van den Kommer

      Affiliations

    • Longitudinal Aging Study Amsterdam and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author at: VU University Medical Center, LASA, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. Tel.: +31 204449337; fax: +31 204446775
  • ,
  • Miranda G. Dik

      Affiliations

    • Longitudinal Aging Study Amsterdam and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands
  • ,
  • Hannie C. Comijs

      Affiliations

    • Longitudinal Aging Study Amsterdam and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands
    • Department of Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands
  • ,
  • Dieter Lütjohann

      Affiliations

    • Institute of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany
  • ,
  • Paul Lips

      Affiliations

    • Department of Internal Medicine, Section Endocrinology, VU University Medical Center, Amsterdam, The Netherlands
  • ,
  • Cees Jonker

      Affiliations

    • Longitudinal Aging Study Amsterdam and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands
  • ,
  • Dorly J.H. Deeg

      Affiliations

    • Longitudinal Aging Study Amsterdam and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands

Received 2 July 2010; received in revised form 15 February 2011; accepted 24 February 2011. published online 13 April 2011.

Abstract 

We examined the associations between extracerebral markers of cholesterol homeostasis and cognitive decline over 6 years of follow-up, and studied the modifying effect of apolipoprotein E (ApoE) e4. Data were collected in the Longitudinal Aging Study Amsterdam (n = 967, with longitudinal data on cognition, ages ≥ 65 years) and analyzed using linear mixed models. General cognition (Mini-Mental State Examination; MMSE), memory (Auditory Verbal Learning Test), and information processing speed (Coding task) were measured. The results show that ApoE e4 was a significant effect modifier. Significant associations were found only in ApoE e4 noncarriers (n = 718). We found a nonlinear negative association between the ratio of lanosterol to cholesterol (≤ 189.96 ng/mg), a marker for cholesterol synthesis, and general cognition. Lower cholesterol absorption, i.e., lower ratios of campesterol and sitosterol to cholesterol, as well as a higher rate of cholesterol synthesis relative to absorption were associated with lower information processing speed. In ApoE e4 carriers, the negative association between the ratio of campesterol to cholesterol and memory reached borderline significance. Future research should focus on the interaction between (disturbed) cholesterol homeostasis and ApoE e4 status with respect to dementia.

Keywords:  Longitudinal population-based study , Extracerebral cholesterol homeostasis , ApoE e4 , Cholesterol precursors , Plant sterols , Trajectory of cognitive functioning

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0197-4580(11)00048-0

doi:10.1016/j.neurobiolaging.2011.02.019

Neurobiology of Aging
Volume 33, Issue 3 , Pages 622.e17-622.e28, March 2012